Drug
Ucart19
Ucart19: highest development phase Phase 1, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| UCART19 NCT02746952 | Phase 1 | B-cell Acute Lymphoblastic Leukemia |
Latest
No recent events.
Follow Ucart19 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.